Thyrocare Divests Radiology Arm Nueclear Healthcare to Trovera for Rs 141.4 Crore
Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 8:32 pm
Thyrocare Divests Radiology Arm Nueclear Healthcare to Trovera for Rs 141.4 Crore Thyrocare Technologies' board approved divesting 100% of wholly owned subsidiary Nueclear Healthcare Limited to Trovera Healthcare for ~Rs 141.40 cr to focus on core pathology. The consideration comprises Rs 81.90 cr in cash (subject to working capital adjustments) and 42,500 CCPS of Trovera valued at Rs 59.50 cr (~4.5% diluted stake). Simultaneously, Thyrocare will acquire operating lab properties in Gurugram and Hyderabad from NHL for Rs 20.59 cr. The transaction requires shareholder approval and is targeted to close by 30th Nov'26.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement 路 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
